Commercial Appeal’s inaugural Healthcare Newsmaker Breakfast spotlights St. Jude Global
Today, the strongest predictor of whether a child is cured of their disease is where the child is born. St. Jude is committed to increasing pediatric cancer survival rates in low- and middle-income countries to 60% by 2030 for the six most common pediatric cancers.
Read More